BCL2 and cancer: These data propose the potential of PE5 as an anticancer approach and lead to a better understanding of ACD regulation, revealing AKT/mTOR as well as Bcl-2 suppression as therapeutic targets for driving cancer cells to autophagy-dependent cell death.